Alpha 2.0
Login Register
» Authors » Yuguang Shang

Yuguang Shang

Explore the profile of Yuguang Shang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 10
Followers 0
Related Specialties
Oncology
Radiology
Top 10 Co-Authors
Jun Zhang
Huina Han
Zhensheng Li
Yue Li
Yunjiang Liu
Kaiye Du
Xiaohui Ji
Longyu Zhu
Dongxing Shen
Zhifeng Jia
Published In
Radiat Oncol
Oncol Lett
Sci Rep
Asian Pac J Cancer Prev
Front Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Single-cell profiling transcriptomic reveals cellular heterogeneity and cellular crosstalk in breast cancer lymphatic node, bone, and brain metastases
Zhu L, Liu M, Shang Y, Cheng J, Zhao H, Zhang J, et al.
Sci Rep . 2025 Jan; 15(1):2217. PMID: 39820531
Breast cancer is the most common malignant tumor in the world, and its metastasis is the main cause of death in breast cancer patients. However, the differences between primary breast...
2.
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy
Li Z, Chen L, Han H, Shang Y, Li Y, Jia Z, et al.
Oncol Res Treat . 2024 Dec; 48(3):112-124. PMID: 39681104
Introduction: Bone-only metastasis (BOM) is a distinct clinical phenomenon in which cancer cells disseminate exclusively to the bones, without involvement of other distant organs. We investigated the factors associated with...
3.
Comparative evaluation of imaging methods for prognosis assessment in esophageal squamous cell carcinoma: focus on diffusion-weighted magnetic resonance imaging, computed tomography and esophagography
Li Y, Su X, Shang Y, Liu H, Wang W, Zhang A, et al.
Front Oncol . 2024 Jul; 14:1397266. PMID: 39026975
Objective: To identify the most sensitive imaging examination method to evaluate the prognosis of esophageal squamous cell carcinoma (ESCC). Materials And Methods: Thirty patients with esophageal squamous cell carcinoma (ESCC)...
4.
Real‑world data indicated that neoadjuvant chemotherapy alone was associated with a higher risk of tumor recurrence in high‑risk breast cancer subgroup patients
Li Z, Li Y, Liu Y, Shang Y, Zhou Y, Ji X, et al.
Oncol Lett . 2023 Apr; 25(5):193. PMID: 37113400
Numerous clinical trials have reported equal effects of tumor control between neoadjuvant chemotherapy (NAC) and adjuvant chemotherapy (AC) in patients with breast cancer (BC). However, this conclusion has not been...
5.
Exploring the relationships between hormone receptor, HER2 status, and bone involvement in the first distant metastases of in Chinese breast cancer patients who lacked HER2 targeted therapy
Jia Z, Dai M, Shang Y, Li Y, Li Z
BMC Cancer . 2023 Jan; 23(1):93. PMID: 36703144
Background: This retrospective study explored the relationship between hormone receptor (HR), human epidermal growth factor receptor 2 (HER2) status, and bone involvement in the first distant metastases (DM) of Chinese...
6.
Full Compliance of Adjuvant Endocrine Therapy Is Associated with Higher Disease-Free Survival in Hormone Receptor-Positive and HER2-Negative Chinese Breast Cancer Patients with First Tumor Recurrence
Li Z, Liu Y, Li Y, Shang Y, Du K, Ji X, et al.
Asian Pac J Cancer Prev . 2022 Oct; 23(10):3413-3420. PMID: 36308366
Purpose: To characterize the compliance status of adjuvant endocrine therapy (aET) and its relationship with disease-free survival (DFS) in hormone receptor-positive (HR+) and HER2-negative (HER2-) in Chinese breast cancer (BC)...
7.
Can internal mammary lymph nodes irradiation bring survival benefits for breast cancer patients? A systematic review and meta-analysis of 12,705 patients in 12 studies
Jia S, Liu Z, Zhang J, Zhao C, Zhu L, Kong J, et al.
Radiat Oncol . 2021 Feb; 16(1):42. PMID: 33622345
Objective: To evaluate the effect of prophylactic irradiation of internal mammary lymph nodes in breast cancer patients. Methods: The computer searched PubMed, EMBASE, Web of science, CNKI, Wanfang Medical Network,...